12:00 AM
Nov 01, 1999
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Advanced Targeting Systems Inc. preclinical data

Advanced Targeting presented data showing that the company's conjugate between the Substance P neurotransmitter and the ribosome-inactivating toxin saporin selectively...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >